Take a deep breath, Friends: the world’s first (seemingly) commercially viable inhalable insulin product is here. Today, Sanofi has officially launched MannKind’s long-awaited Afrezza, and we hear the product is already appearing in some pharmacie…
SOURCE: Healthline RSS Feed – Read entire story here.